Clinical Trial Update: Effects of Inhaled Treprostinil on Exercise Performance in Exercise Induced Pulmonary Hypertension [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of inhaled treprostinil for exercise-induced pulmonary hypertension, which is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exercise-induced Pulmonary Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Treprostinil (inhaled) (treprostinil)

Snippet

Sponsor: University of California, San Diego | Conditions: Pulmonary Hypertension | EARLY_Phase 1 | Status: NOT_YET_RECRUITING